Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized Human Rabies Vaccine (Vero Cell) 5-dose Regimen Persistence Study
CTR20192732Phase 4Completed
- Sponsor
- Changchun Weiersai Pharmaceutical
- Start
- Jan 2020
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Rabies vaccine in rabies, sponsored by Changchun Weiersai Pharmaceutical. Started Jan 2020; status: completed.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20192732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192732.